{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:21:29Z","timestamp":1700317289370},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1405,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:p>Monoclonal antibodies (MoAbs 833 and D4H1) directed against human factor VIII (FVIII) have been produced on a large scale to measure VIII:CAg by two\u2010site ELISA (Asserachrom VIII:CAg, Diagnostica Stago). F(ab\u2019)<jats:sub>2<\/jats:sub> from MoAb 833 were used for coating and bound VIII:CAg was revealed with MoAb D4H1 coupled to peroxidase. Control plasma (100 VIII:CAg U dL<jats:sup>\u22121<\/jats:sup> by comparing with the International Standard) was used as reference. The assay sensitivity was 0.1 U dL<jats:sup>\u22121<\/jats:sup> VIII:CAg. No apparent effect of the plasma proteins was observed provided plasma dilution was  5. Thus this ELISA allowed us to estimate VIII:CAg levels of 0.5 U dL<jats:sup>\u22121<\/jats:sup> in plasma. Levels of VIII:CAg were similar to those of VIII:C (correlation coefficient <jats:italic>r<\/jats:italic>= 0.87) in plasma from normal individuals (32 cases) and in patients with von Willebrand disease of various types (30 cases). Among 294 patients with Haemophilia A (HA), 161 had severe HA (VIII:C &lt; 1 U dL<jats:sup>\u22121<\/jats:sup>). Among those patients, 124 were cross\u2010reacting material (CRM) negative with undetectable VIII:CAg and 37 were CRM+ (VIII:CAg 1\u2013 31 U dL<jats:sup>\u22121<\/jats:sup>). In 42 patients with moderate HA (VIII:C 1\u2013 5 U dL<jats:sup>\u22121<\/jats:sup>), 33 were CRM reduced (VIII:CAg 0.5\u20138 U dL<jats:sup>\u22121<\/jats:sup>) and nine were CRM+ with a VIII:CAg\/VIII:C ratio of 6\u201391 (mean 34.3). In mild HA (91 cases with VIII:C  6 U dL<jats:sup>\u22121<\/jats:sup>), 29 patients were classified as CRM+ (VIII:C 6\u201357 U dL<jats:sup>\u22121<\/jats:sup>, VIII:CAg 17\u2013130 U dL<jats:sup>\u22121<\/jats:sup> and VIII:CAg\/VIII:C ratio 1.8\u201313.7 (mean 4.51)). In 62 CRM reduced patients there was a linear correlation between VIII:C (6\u201339 U dL<jats:sup>\u22121<\/jats:sup>) and VIII:CAg (2\u201336 U dL<jats:sup>\u22121<\/jats:sup>) levels (<jats:italic>r<\/jats:italic>= 0.88). In conclusion, this sensitive assay allows us to distinguish the quantitative CRM reduced and negative from the qualitative (CRM+) abnormalities in Haemophilia A.<\/jats:p>","DOI":"10.1046\/j.1365-2516.1998.00149.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T22:54:03Z","timestamp":1047423243000},"page":"98-103","source":"Crossref","is-referenced-by-count":13,"title":["Assay of factor VIII antigen (VIII:CAg) in 294 Haemophilia A patients by a new commercial ELISA using monoclonal antibodies"],"prefix":"10.1111","volume":"4","author":[{"family":"Girma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Houllier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Laurian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Amiral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface\u2010dependent reactions of the vitamin K\u2010dependent enzyme complexes.","volume":"76","author":"Mann KG","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/312342a0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/312337a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/312330a0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.9.2979"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00350a035"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V59.3.594.594","article-title":"Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein.","volume":"59","author":"Fass DN","year":"1982","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(86)90208-6"},{"key":"e_1_2_6_10_2","unstructured":"SadlerJE&DavieEW.In: Stamatoyannopoulos G Nienhuis A Leder P Majeru P eds.The Molecular Basis of Blood Diseases. Philadelphia: WB Saunders 1987;575630."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401063300108"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood.V32.6.962.962","article-title":"Immunologic studies of anti\u2010hemophilic factor (AHF, factor VIII): cross\u2010reactive material in a genetic variant of hemophilia A.","volume":"32","author":"Hoyer LW","year":"1968","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109209"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood.V56.4.615.615","article-title":"Factor VIII coagulant antigen. A comparison of five allo\u2010antibodies.","volume":"56","author":"Reisner HM","year":"1980","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02788.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb01131.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(79)90042-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1979.tb02847.x"},{"key":"e_1_2_6_19_2","first-page":"223","article-title":"Development, optimization and use of an enzyme linked immunosorbent assay (ELISA) to measure factor VIII\u2010antigen utilizing monoclonal antibodies.","volume":"2","author":"Hornsey VS","year":"1992","journal-title":"Trans Med Soc Lond"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII.","volume":"5","author":"Nishino M","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2820129"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02937.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(81)90783-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/22.12.1084"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(78)91322-0"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4117.1149"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.1998.00149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.1998.00149.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2516.1998.00149.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.1998.00149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T01:48:57Z","timestamp":1694396937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2516.1998.00149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1046\/j.1365-2516.1998.00149.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2516.1998.00149.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}